R01 CA141303/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	1
2010	10
2011	9
2012	9
2013	10
2014	7
2015	7
2016	6
2024	0

1

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells.

Denman CJ, Senyukov VV, Somanchi SS, Phatarpekar PV, Kopp LM, Johnson JL, Singh H, Hurton L, Maiti SN, Huls MH, Champlin RE, Cooper LJ, Lee DA. Denman CJ, et al. PLoS One. 2012;7(1):e30264. doi: 10.1371/journal.pone.0030264. Epub 2012 Jan 18. PLoS One. 2012. PMID: 22279576 Free PMC article.

2

Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.

Hurton LV, Singh H, Najjar AM, Switzer KC, Mi T, Maiti S, Olivares S, Rabinovich B, Huls H, Forget MA, Datar V, Kebriaei P, Lee DA, Champlin RE, Cooper LJ. Hurton LV, et al. Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7788-E7797. doi: 10.1073/pnas.1610544113. Epub 2016 Nov 14. Proc Natl Acad Sci U S A. 2016. PMID: 27849617 Free PMC article.

3

Driving CAR-based T-cell therapy to success.

Jena B, Moyes JS, Huls H, Cooper LJ. Jena B, et al. Curr Hematol Malig Rep. 2014 Mar;9(1):50-6. doi: 10.1007/s11899-013-0197-7. Curr Hematol Malig Rep. 2014. PMID: 24488441 Free PMC article. Review.

4

Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.

Jena B, Dotti G, Cooper LJ. Jena B, et al. Blood. 2010 Aug 19;116(7):1035-44. doi: 10.1182/blood-2010-01-043737. Epub 2010 May 3. Blood. 2010. PMID: 20439624 Free PMC article. Review.

5

Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".

Capitini CM, Gottschalk S, Brenner M, Cooper LJ, Handgretinger R, Mackall CL. Capitini CM, et al. Pediatr Hematol Oncol. 2011 Sep;28(6):459-60. doi: 10.3109/08880018.2011.596615. Pediatr Hematol Oncol. 2011. PMID: 21854215 Review.

6

Imaging of T cells expressing chimeric antigen receptors.

Roszik J, Rabinovich B, Cooper LJ. Roszik J, et al. Immunotherapy. 2011 Dec;3(12):1411-4. doi: 10.2217/imt.11.138. Immunotherapy. 2011. PMID: 22091674 No abstract available.

7

Off-the-shelf T-cell therapy.

Cooper LJ. Cooper LJ. Blood. 2010 Dec 2;116(23):4741-3. doi: 10.1182/blood-2010-10-308379. Blood. 2010. PMID: 21127184 Free article. No abstract available.

8

Clinical applications of gamma delta T cells with multivalent immunity.

Deniger DC, Moyes JS, Cooper LJ. Deniger DC, et al. Front Immunol. 2014 Dec 11;5:636. doi: 10.3389/fimmu.2014.00636. eCollection 2014. Front Immunol. 2014. PMID: 25566249 Free PMC article. Review.

9

CARs in chronic lymphocytic leukemia -- ready to drive.

Hosing C, Kebriaei P, Wierda W, Jena B, Cooper LJN, Shpall E. Hosing C, et al. Curr Hematol Malig Rep. 2013 Mar;8(1):60-70. doi: 10.1007/s11899-012-0145-y. Curr Hematol Malig Rep. 2013. PMID: 23225251 Free PMC article. Review.

10

Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy.

Hackett PB, Largaespada DA, Switzer KC, Cooper LJ. Hackett PB, et al. Transl Res. 2013 Apr;161(4):265-83. doi: 10.1016/j.trsl.2012.12.005. Epub 2013 Jan 10. Transl Res. 2013. PMID: 23313630 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year